Journal: EMBO Reports
Article Title: Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors
doi: 10.1038/s44319-024-00089-7
Figure Lengend Snippet: HCT116, HT-29 and SiHa cancer cells were chronically adapted at pH 6.5 or maintained at pH 7.4 ( A , C , D ) or native HCT116 cells were acutely exposed to acidic pH e ( B ) or treated with 5-FU at the indicated doses to be compared with cancer cells adapted at pH 6.5 ( E , F ). ( A – C ) Representative immunoblots of total and phosphorylated ATM, ATR, CHK1, CHK2. Actin or tubulin was used as loading control, as indicated. ( D ) Bar graph showing the proportion of tetraploid cells. ( E , F ) Representative immunoblots of total and phosphorylated ATM, ATR, CHK1, CHK2. Actin was used as loading control, as indicated. ( G – J ) Cell viability assays in HCT116 ( G , I ) and HT-29 cancer cells ( H , J ) cultured at pH 7.4 or 6.5, and treated with the indicated doses of ATMi AZD0156 ( G , H ) or ATRi elimusertib ( I , J ) for 72 h. Data information: ( A – J ) data represent n = 3 independent biological replicates. ( D , G – J ) Bar graphs represent means ± SD with three biological replicates ( D ) or six technical replicates ( G – J ), and significance was determined using two-way ANOVA with Tukey’s multiple-comparison analysis (ns non-significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001). .
Article Snippet: Antibodies targeted against phosphorylated p-ATM (D25E5) (Ser-1981) (1:1000), ATM (D2E2) (1:1000), p-ATR (D5K8W) (Thr-1989) (1:1000), ATR (E1S3S) (1:1000), p-CHK1 (133D3) (Ser-345) (1:1000), CHK1 (2G1D5) (1:1000), p-CHK2 (C13C1) (Thr-68) (1:1000), CHK2 (1C12) (1:1000) and α/β-tubulin (1:2000) are from Cell Signaling Technologies; β-Actin (AC-15) (1:30,000) from Sigma-Aldrich.
Techniques: Western Blot, Cell Culture, Comparison